Timothy M. Dall

The Economic Burden Of Diabetes

New research provides revised comprehensive estimates that suggest that the U.S. national economic burden of pre-diabetes and diabetes reached

The current and projected economic burden of Parkinson's disease in the United States

218 billion in 2007. This estimate includes

The Economic Burden of Elevated Blood Glucose Levels in 2012: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes

153 billion in higher medical costs and

The Economic Value of Professional Nursing

65 billion in reduced productivity. The average annual cost per case is

Supply and demand analysis of the current and future US neurology workforce

2,864 for undiagnosed diabetes,

Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet.

9,975 for diagnosed diabetes (

Cost Associated With Being Overweight and With Obesity, High Alcohol Consumption, and Tobacco Use Within the Military Health System's TRICARE Prime–Enrolled Population

9,677 for type 2 and

Cost of Gestational Diabetes Mellitus in the United States in 2007

14,856 for type 1), and

Modeling the indirect economic implications of musculoskeletal disorders and treatment.

443 for pre-diabetes (medical costs only). For each American, regardless of diabetes status, this burden represents a cost of approximately

Medical Cost Associated with Prediabetes

700 annually. These results underscore the urgency of better understanding how prevention and treatment strategies may or may not help reduce costs.